Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Oligodendroglioma × Restraint, Physical × Clear all

Sponsor

Conditions

Squamous Cell Carcinoma of Head and Neck 2 Oropharyngeal Neoplasms 2 Head and Neck Neoplasms 2 Carcinoma, Squamous Cell 2 Testicular Neoplasms 1 Teratoma 1 Sarcoma 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Ovarian Germ Cell Cancer 1 Ototoxicity 1 Osteosarcoma 1 Neuroblastoma 1 Medulloblastoma 1 Liver Neoplasms 1 Hepatoblastoma 1 Hematologic Neoplasms 1 Frailty 1 Central Nervous System Neoplasms 1 Brain Neoplasms 1

Interventions

Temozolomide 14 Bevacizumab 11 Erlotinib Hydrochloride 5 Radiotherapy 4 Carboplatin 4 Magnetic Resonance Spectroscopy 3 Irinotecan 3 Immunoglobulin G 3 Disulfides 3 temsirolimus 2 poly ICLC 2 palbociclib 2 etoposide phosphate 2 antineoplaston AS 2-1 2 antineoplaston A10 2 Vincristine 2 Sunitinib 2 Sirolimus 2 Everolimus 2 Dasatinib 2 2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 2 veliparib 1 varlilumab 1 vandetanib 1 trebananib 1 trametinib 1 terameprocol 1 tandutinib 1 selinexor 1 romidepsin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡